TriSalus Life Sciences Warrant
TLSIW
26 hedge funds and large institutions have $8.05M invested in TriSalus Life Sciences Warrant in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 10 closing their positions.
50% more capital invested
Capital invested by funds: $5.36M → $8.05M (+$2.68M)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
13% less funds holding
Funds holding: 30 → 26 (-4)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
Top Buyers
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$288K |
| 2 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$215K |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$73.7K |
| 4 |
IM
Islet Management
New York
|
+$70.5K |
| 5 |
MP
MSD Partners
New York
|
+$57.3K |
Top Sellers
| 1 |
BlackRock
New York
|
-$473K |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$217K |
| 3 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$205K |
| 4 |
GL
Governors Lane
New York
|
-$133K |
| 5 |
LA
Linden Advisors
New York
|
-$132K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| $1K | -$226 | -525 | -10% |
|
|
27
BlackRock
New York
| – | -$473K | -909,649 | Closed |
|
|
PWAM
28
Park West Asset Management
San Francisco,
California
| – | -$217K | -416,666 | Closed |
|
|
AC
29
Aristeia Capital
Greenwich,
Connecticut
| – | -$205K | -384,495 | Closed |
|
|
GL
30
Governors Lane
New York
| – | -$133K | -250,000 | Closed |
|
|
LA
31
Linden Advisors
New York
| – | -$132K | -246,601 | Closed |
|
|
CH
32
CVI Holdings
Wilmington,
Delaware
| – | -$43K | -83,333 | Closed |
|
|
ICMH
33
Integrity Capital Management (HK)
Central,
Hong Kong
| – | -$30K | -56,623 | Closed |
|
|
MS
34
Maven Securities
St Helier,
Jersey
| – | -$25K | -48,665 | Closed |
|
|
CM
35
CastleKnight Management
New York
| – | -$19.9K | -46,371 | Closed |
|
|
KJHP
36
K.J. Harrison & Partners
Toronto,
Ontario, Canada
| – | -$7K | -12,990 | Closed |
|
TLSIW Hedge Fund Activity: Q1 2022 in Review
26 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q1 2022, worth a combined $8.05M — up 50% from $5.36M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of TLSIW and 6 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 4 added.
The largest buyer was Magnetar Financial, adding an estimated $288K. The largest seller was BlackRock, exiting entirely with an estimated $473K sold.
- 26 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q1 2022, down from 30 in Q4 2021.
- Funds reported $8.05M of TriSalus Life Sciences Warrant stock for Q1 2022, up 50% quarter-over-quarter.
- 6 funds opened new TriSalus Life Sciences Warrant positions in Q1 2022 and 10 closed out, a net change of -4 holders.
- The largest TriSalus Life Sciences Warrant buyer in Q1 2022 was Magnetar Financial, an estimated $288K added.
- The largest TriSalus Life Sciences Warrant seller in Q1 2022 was BlackRock, an estimated $473K sold.
Based on aggregated 13F filings for Q1 2022.